nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—HTR1B—cranial nerve—salivary gland cancer	0.0636	0.171	CbGeAlD
Bromocriptine—HTR1D—cranial nerve—salivary gland cancer	0.0615	0.166	CbGeAlD
Bromocriptine—HTR7—cranial nerve—salivary gland cancer	0.049	0.132	CbGeAlD
Bromocriptine—HTR2A—cranial nerve—salivary gland cancer	0.0306	0.0824	CbGeAlD
Bromocriptine—ADRA1D—epithelium—salivary gland cancer	0.0161	0.0435	CbGeAlD
Bromocriptine—DRD5—lymphoid tissue—salivary gland cancer	0.0155	0.0417	CbGeAlD
Bromocriptine—HTR7—neck—salivary gland cancer	0.0141	0.038	CbGeAlD
Bromocriptine—HTR1D—connective tissue—salivary gland cancer	0.0127	0.0342	CbGeAlD
Bromocriptine—ADRB1—connective tissue—salivary gland cancer	0.0123	0.0333	CbGeAlD
Bromocriptine—ADRA2C—parotid gland—salivary gland cancer	0.0106	0.0285	CbGeAlD
Bromocriptine—HTR7—connective tissue—salivary gland cancer	0.0101	0.0273	CbGeAlD
Bromocriptine—HTR7—epithelium—salivary gland cancer	0.0096	0.0259	CbGeAlD
Bromocriptine—ADRA1A—epithelium—salivary gland cancer	0.00926	0.025	CbGeAlD
Bromocriptine—HTR2A—neck—salivary gland cancer	0.0088	0.0237	CbGeAlD
Bromocriptine—ADRA2A—connective tissue—salivary gland cancer	0.00742	0.02	CbGeAlD
Bromocriptine—ADRA1A—lymphoid tissue—salivary gland cancer	0.00713	0.0192	CbGeAlD
Bromocriptine—HTR2A—connective tissue—salivary gland cancer	0.00631	0.017	CbGeAlD
Bromocriptine—HTR2A—epithelium—salivary gland cancer	0.00599	0.0161	CbGeAlD
Bromocriptine—HTR2B—lymph node—salivary gland cancer	0.00487	0.0131	CbGeAlD
Bromocriptine—ABCB1—epithelium—salivary gland cancer	0.00392	0.0106	CbGeAlD
Bromocriptine—ADRA2C—lymph node—salivary gland cancer	0.00383	0.0103	CbGeAlD
Bromocriptine—ADRA2A—lymph node—salivary gland cancer	0.00306	0.00825	CbGeAlD
Bromocriptine—ABCB1—lymphoid tissue—salivary gland cancer	0.00302	0.00815	CbGeAlD
Bromocriptine—ABCB1—lymph node—salivary gland cancer	0.00171	0.0046	CbGeAlD
Bromocriptine—HTR7—Signaling Pathways—CREBBP—salivary gland cancer	0.000168	0.000267	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000167	0.000266	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CREBBP—salivary gland cancer	0.000167	0.000265	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAP2K2—salivary gland cancer	0.000166	0.000265	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NUP62—salivary gland cancer	0.000166	0.000264	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—HRAS—salivary gland cancer	0.000165	0.000263	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—VCAN—salivary gland cancer	0.000165	0.000262	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CREBBP—salivary gland cancer	0.000163	0.000259	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAP2K2—salivary gland cancer	0.000162	0.000257	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000162	0.000257	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—FOXO3—salivary gland cancer	0.000161	0.000256	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CCND1—salivary gland cancer	0.000161	0.000256	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CREBBP—salivary gland cancer	0.000161	0.000255	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000159	0.000254	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000159	0.000253	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000158	0.000251	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000158	0.00025	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NOTCH1—salivary gland cancer	0.000157	0.00025	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NOTCH1—salivary gland cancer	0.000157	0.00025	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000157	0.000249	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—PTEN—salivary gland cancer	0.000155	0.000247	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CREBBP—salivary gland cancer	0.000153	0.000244	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000153	0.000244	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000151	0.00024	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—EP300—salivary gland cancer	0.000148	0.000236	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000147	0.000234	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—PIK3CA—salivary gland cancer	0.000145	0.000231	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000145	0.00023	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000145	0.00023	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CREBBP—salivary gland cancer	0.000145	0.00023	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000144	0.000229	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—CREBBP—salivary gland cancer	0.000144	0.000229	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000143	0.000228	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000143	0.000228	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000143	0.000227	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CREBBP—salivary gland cancer	0.000143	0.000227	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CREBBP—salivary gland cancer	0.000143	0.000227	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000142	0.000226	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000142	0.000226	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000142	0.000225	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—TP53—salivary gland cancer	0.00014	0.000223	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000139	0.000221	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000137	0.000218	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000137	0.000218	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NOTCH1—salivary gland cancer	0.000136	0.000217	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000136	0.000216	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—HRAS—salivary gland cancer	0.000134	0.000214	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000134	0.000213	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000134	0.000213	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NOTCH1—salivary gland cancer	0.000133	0.000211	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—HRAS—salivary gland cancer	0.000133	0.000211	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—HRAS—salivary gland cancer	0.000132	0.00021	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000132	0.000209	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—HRAS—salivary gland cancer	0.000132	0.000209	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000131	0.000208	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000131	0.000208	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CREBBP—salivary gland cancer	0.00013	0.000207	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CREBBP—salivary gland cancer	0.000129	0.000205	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—HRAS—salivary gland cancer	0.000129	0.000205	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000128	0.000204	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000127	0.000203	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—HRAS—salivary gland cancer	0.000127	0.000201	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CREBBP—salivary gland cancer	0.000124	0.000198	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CCND1—salivary gland cancer	0.000124	0.000198	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CCND1—salivary gland cancer	0.000124	0.000197	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CREBBP—salivary gland cancer	0.000124	0.000197	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CCND1—salivary gland cancer	0.000123	0.000196	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000123	0.000196	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000122	0.000194	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000122	0.000193	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000122	0.000193	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—HRAS—salivary gland cancer	0.000121	0.000192	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000121	0.000192	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CCND1—salivary gland cancer	0.000121	0.000192	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NOTCH1—salivary gland cancer	0.00012	0.000191	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CREBBP—salivary gland cancer	0.00012	0.000191	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PTEN—salivary gland cancer	0.00012	0.000191	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PTEN—salivary gland cancer	0.00012	0.00019	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PTEN—salivary gland cancer	0.000119	0.000189	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CCND1—salivary gland cancer	0.000119	0.000189	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000118	0.000188	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CREBBP—salivary gland cancer	0.000118	0.000188	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—CREBBP—salivary gland cancer	0.000117	0.000186	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000117	0.000186	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PTEN—salivary gland cancer	0.000117	0.000185	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000116	0.000185	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000116	0.000184	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PTEN—salivary gland cancer	0.000115	0.000182	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EP300—salivary gland cancer	0.000114	0.000182	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EP300—salivary gland cancer	0.000114	0.000182	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—HRAS—salivary gland cancer	0.000114	0.000181	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EP300—salivary gland cancer	0.000114	0.00018	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CCND1—salivary gland cancer	0.000113	0.00018	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000113	0.00018	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—HRAS—salivary gland cancer	0.000113	0.000179	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—HRAS—salivary gland cancer	0.000113	0.000179	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000111	0.000177	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EP300—salivary gland cancer	0.000111	0.000177	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000111	0.000176	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00011	0.000175	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—PIK3CA—salivary gland cancer	0.00011	0.000174	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PTEN—salivary gland cancer	0.000109	0.000174	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EP300—salivary gland cancer	0.000109	0.000174	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CREBBP—salivary gland cancer	0.000109	0.000174	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000108	0.000171	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CREBBP—salivary gland cancer	0.000107	0.000171	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CCND1—salivary gland cancer	0.000107	0.00017	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—salivary gland cancer	0.000106	0.000169	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000106	0.000169	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCND1—salivary gland cancer	0.000106	0.000168	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCND1—salivary gland cancer	0.000106	0.000168	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000105	0.000168	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CREBBP—salivary gland cancer	0.000105	0.000167	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EP300—salivary gland cancer	0.000104	0.000166	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000103	0.000164	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PTEN—salivary gland cancer	0.000103	0.000164	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PTEN—salivary gland cancer	0.000103	0.000163	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000103	0.000163	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—HRAS—salivary gland cancer	0.000103	0.000163	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000103	0.000163	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PTEN—salivary gland cancer	0.000102	0.000162	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PTEN—salivary gland cancer	0.000102	0.000162	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—HRAS—salivary gland cancer	0.000102	0.000162	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—HRAS—salivary gland cancer	0.000101	0.000161	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000101	0.000161	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000101	0.00016	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.88e-05	0.000157	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	9.87e-05	0.000157	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EP300—salivary gland cancer	9.85e-05	0.000157	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—HRAS—salivary gland cancer	9.81e-05	0.000156	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—EP300—salivary gland cancer	9.8e-05	0.000156	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CREBBP—salivary gland cancer	9.77e-05	0.000155	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—HRAS—salivary gland cancer	9.76e-05	0.000155	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EP300—salivary gland cancer	9.72e-05	0.000154	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EP300—salivary gland cancer	9.72e-05	0.000154	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCND1—salivary gland cancer	9.62e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCND1—salivary gland cancer	9.53e-05	0.000151	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—HRAS—salivary gland cancer	9.49e-05	0.000151	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—HRAS—salivary gland cancer	9.34e-05	0.000149	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—PIK3CA—salivary gland cancer	9.31e-05	0.000148	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PTEN—salivary gland cancer	9.28e-05	0.000148	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCND1—salivary gland cancer	9.2e-05	0.000146	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PTEN—salivary gland cancer	9.2e-05	0.000146	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.18e-05	0.000146	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—PIK3CA—salivary gland cancer	9.16e-05	0.000146	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCND1—salivary gland cancer	9.15e-05	0.000145	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—PIK3CA—salivary gland cancer	8.97e-05	0.000143	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCND1—salivary gland cancer	8.9e-05	0.000142	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PTEN—salivary gland cancer	8.88e-05	0.000141	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EP300—salivary gland cancer	8.85e-05	0.000141	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PTEN—salivary gland cancer	8.83e-05	0.00014	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EP300—salivary gland cancer	8.77e-05	0.000139	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCND1—salivary gland cancer	8.76e-05	0.000139	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—HRAS—salivary gland cancer	8.61e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PTEN—salivary gland cancer	8.59e-05	0.000137	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—HRAS—salivary gland cancer	8.47e-05	0.000135	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EP300—salivary gland cancer	8.47e-05	0.000135	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PIK3CA—salivary gland cancer	8.46e-05	0.000135	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PTEN—salivary gland cancer	8.46e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PIK3CA—salivary gland cancer	8.45e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EP300—salivary gland cancer	8.42e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PIK3CA—salivary gland cancer	8.4e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTEN—salivary gland cancer	8.35e-05	0.000133	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—PIK3CA—salivary gland cancer	8.33e-05	0.000132	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—HRAS—salivary gland cancer	8.3e-05	0.000132	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—salivary gland cancer	8.22e-05	0.000131	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EP300—salivary gland cancer	8.19e-05	0.00013	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—salivary gland cancer	8.19e-05	0.00013	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—salivary gland cancer	8.18e-05	0.00013	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—salivary gland cancer	8.12e-05	0.000129	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—salivary gland cancer	8.09e-05	0.000129	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CREBBP—salivary gland cancer	8.08e-05	0.000128	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—salivary gland cancer	8.08e-05	0.000128	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EP300—salivary gland cancer	8.06e-05	0.000128	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—EP300—salivary gland cancer	7.96e-05	0.000127	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—salivary gland cancer	7.95e-05	0.000126	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—salivary gland cancer	7.95e-05	0.000126	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—salivary gland cancer	7.83e-05	0.000124	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—salivary gland cancer	7.83e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—salivary gland cancer	7.82e-05	0.000124	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—salivary gland cancer	7.8e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—salivary gland cancer	7.78e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—salivary gland cancer	7.77e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—salivary gland cancer	7.72e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—salivary gland cancer	7.71e-05	0.000123	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—salivary gland cancer	7.67e-05	0.000122	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—salivary gland cancer	7.61e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—salivary gland cancer	7.51e-05	0.000119	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—salivary gland cancer	7.49e-05	0.000119	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—salivary gland cancer	7.47e-05	0.000119	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EP300—salivary gland cancer	7.43e-05	0.000118	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EP300—salivary gland cancer	7.31e-05	0.000116	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.3e-05	0.000116	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—salivary gland cancer	7.28e-05	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—salivary gland cancer	7.25e-05	0.000115	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—salivary gland cancer	7.23e-05	0.000115	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—salivary gland cancer	7.19e-05	0.000114	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—salivary gland cancer	7.19e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EP300—salivary gland cancer	7.16e-05	0.000114	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—salivary gland cancer	7.15e-05	0.000114	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—salivary gland cancer	7.05e-05	0.000112	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—salivary gland cancer	6.98e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—salivary gland cancer	6.95e-05	0.000111	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—salivary gland cancer	6.95e-05	0.000111	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—salivary gland cancer	6.74e-05	0.000107	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EP300—salivary gland cancer	6.65e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—salivary gland cancer	6.65e-05	0.000106	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—salivary gland cancer	6.65e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—salivary gland cancer	6.55e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—salivary gland cancer	6.49e-05	0.000103	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CREBBP—salivary gland cancer	6.45e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—salivary gland cancer	6.33e-05	0.000101	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—salivary gland cancer	6.28e-05	9.98e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—salivary gland cancer	6.26e-05	9.96e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—salivary gland cancer	6.23e-05	9.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—salivary gland cancer	6.06e-05	9.64e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—salivary gland cancer	6.06e-05	9.63e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—salivary gland cancer	6.06e-05	9.63e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—salivary gland cancer	6.03e-05	9.58e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—salivary gland cancer	6e-05	9.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—salivary gland cancer	5.96e-05	9.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—salivary gland cancer	5.89e-05	9.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—salivary gland cancer	5.86e-05	9.32e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—salivary gland cancer	5.79e-05	9.21e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—salivary gland cancer	5.77e-05	9.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—salivary gland cancer	5.77e-05	9.17e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—salivary gland cancer	5.77e-05	9.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—salivary gland cancer	5.61e-05	8.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—salivary gland cancer	5.52e-05	8.77e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—EP300—salivary gland cancer	5.5e-05	8.75e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—salivary gland cancer	5.5e-05	8.74e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—salivary gland cancer	5.41e-05	8.6e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—salivary gland cancer	5.32e-05	8.46e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—salivary gland cancer	5.3e-05	8.42e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—salivary gland cancer	5.23e-05	8.32e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—salivary gland cancer	5.13e-05	8.15e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—salivary gland cancer	5.09e-05	8.09e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—salivary gland cancer	5.01e-05	7.96e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CREBBP—salivary gland cancer	4.98e-05	7.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—salivary gland cancer	4.92e-05	7.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—salivary gland cancer	4.9e-05	7.79e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—salivary gland cancer	4.76e-05	7.57e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—salivary gland cancer	4.61e-05	7.32e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—salivary gland cancer	4.55e-05	7.24e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—EP300—salivary gland cancer	4.39e-05	6.98e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—salivary gland cancer	4.07e-05	6.47e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—salivary gland cancer	3.56e-05	5.65e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—EP300—salivary gland cancer	3.39e-05	5.39e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	3.25e-05	5.17e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	2.51e-05	3.99e-05	CbGpPWpGaD
